{ "industryId": "medicalDevice", "name": "의료기기", "totalRevenue": 58351, "nodeCount": 57, "stages": [ { "key": "diagnostic", "name": "진단", "role": "제조", "stream": "midstream", "nodes": [ { "stockCode": "099190", "corpName": "아이센스", "stage": "diagnostic", "role": "제조", "stream": "midstream", "revenue": 3154, "confidence": 0.7, "source": "product", "roe": 0.5, "opMargin": 1.2, "debtRatio": 65.8, "revCagr": -34.3, "profGrade": "저수익", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "206640", "corpName": "바디텍메드", "stage": "diagnostic", "role": "제조", "stream": "midstream", "revenue": 1621, "confidence": 0.867, "source": "docs", "roe": 3.9, "opMargin": 15.9, "debtRatio": 16.0, "revCagr": -31.7, "profGrade": "양호", "debtGrade": "안전", "growthGrade": "역성장" }, { "stockCode": "036220", "corpName": "오상헬스케어", "stage": "diagnostic", "role": "제조", "stream": "midstream", "revenue": 1286, "confidence": 0.933, "source": "docs", "roe": -1.3, "opMargin": -19.2, "debtRatio": 21.3, "revCagr": -56.9, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "303360", "corpName": "프로티아", "stage": "diagnostic", "role": "제조", "stream": "midstream", "revenue": 151, "confidence": 0.9, "source": "docs", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" }, { "stockCode": "314930", "corpName": "바이오다인", "stage": "diagnostic", "role": "제조", "stream": "midstream", "revenue": 70, "confidence": 0.8, "source": "docs", "roe": 0.4, "opMargin": -46.5, "debtRatio": 1.1, "revCagr": -87.7, "profGrade": "저수익", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "317690", "corpName": "퀀타매트릭스", "stage": "diagnostic", "role": "제조", "stream": "midstream", "revenue": 37, "confidence": 1.0, "source": "docs", "roe": -13.0, "opMargin": -556.1, "debtRatio": 33.4, "revCagr": 14.3, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "성장" }, { "stockCode": "336040", "corpName": "타스컴", "stage": "diagnostic", "role": "제조", "stream": "midstream", "revenue": 0, "confidence": 0.867, "source": "docs", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" } ] }, { "key": "therapeutic", "name": "치료", "role": "제조", "stream": "midstream", "nodes": [ { "stockCode": "261200", "corpName": "덴티스", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 1142, "confidence": 0.7, "source": "product", "roe": 11.7, "opMargin": 10.1, "debtRatio": 328.0, "revCagr": 5.5, "profGrade": "양호", "debtGrade": "관찰", "growthGrade": "성장" }, { "stockCode": "104540", "corpName": "코렌텍", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 1004, "confidence": 0.5, "source": "docs", "roe": 90.0, "opMargin": 3.6, "debtRatio": 77.4, "revCagr": -35.6, "profGrade": "우수", "debtGrade": "관찰", "growthGrade": "급감" }, { "stockCode": "372910", "corpName": "한컴라이프케어", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 921, "confidence": 0.3, "source": "docs", "roe": -1.8, "opMargin": -63.7, "debtRatio": 61.8, "revCagr": -11.4, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "0011A0", "corpName": "액스비스", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 566, "confidence": 0.7, "source": "product", "roe": 2.0, "opMargin": 7.1, "debtRatio": 75.5, "revCagr": -80.4, "profGrade": "보통", "debtGrade": "관찰", "growthGrade": "급감" }, { "stockCode": "044780", "corpName": "에이치케이", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 542, "confidence": 0.7, "source": "product", "roe": 1.4, "opMargin": -43.7, "debtRatio": 42.6, "revCagr": -35.7, "profGrade": "저수익", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "115480", "corpName": "씨유메디칼", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 482, "confidence": 0.5, "source": "docs", "roe": 3.8, "opMargin": 16.6, "debtRatio": 82.2, "revCagr": 20.8, "profGrade": "양호", "debtGrade": "안전", "growthGrade": "고성장" }, { "stockCode": "226400", "corpName": "오스테오닉", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 454, "confidence": 0.7, "source": "product", "roe": 3.8, "opMargin": 18.1, "debtRatio": 58.6, "revCagr": 27.4, "profGrade": "양호", "debtGrade": "안전", "growthGrade": "고성장" }, { "stockCode": "199550", "corpName": "레이저옵텍", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 257, "confidence": 0.7, "source": "product", "roe": -5.6, "opMargin": -30.7, "debtRatio": 69.1, "revCagr": -56.1, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "452190", "corpName": "한빛레이저", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 242, "confidence": 0.7, "source": "product", "roe": 1.0, "opMargin": 2.7, "debtRatio": 31.2, "revCagr": -34.7, "profGrade": "저수익", "debtGrade": "관찰", "growthGrade": "급감" }, { "stockCode": "066310", "corpName": "큐에스아이", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 233, "confidence": 0.7, "source": "product", "roe": 2.5, "opMargin": 8.7, "debtRatio": 7.2, "revCagr": 7.1, "profGrade": "보통", "debtGrade": "안전", "growthGrade": "정체" }, { "stockCode": "388790", "corpName": "라이콤", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 177, "confidence": 0.8, "source": "docs", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" }, { "stockCode": "043100", "corpName": "알파AI", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 168, "confidence": 0.6, "source": "docs", "roe": 119.1, "opMargin": -43.7, "debtRatio": 160.5, "revCagr": -18.4, "profGrade": "우수", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "199290", "corpName": "바이오프로테크", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 0, "confidence": 0.6, "source": "docs", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" }, { "stockCode": "200580", "corpName": "메디쎄이", "stage": "therapeutic", "role": "제조", "stream": "midstream", "revenue": 0, "confidence": 0.7, "source": "product", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" } ] }, { "key": "imaging", "name": "영상", "role": "제조", "stream": "midstream", "nodes": [ { "stockCode": "011560", "corpName": "세보엠이씨", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 7158, "confidence": 0.7, "source": "product", "roe": 90.5, "opMargin": 6.4, "debtRatio": 61.9, "revCagr": -34.4, "profGrade": "우수", "debtGrade": "안전", "growthGrade": "급감" }, { "stockCode": "092790", "corpName": "넥스틸", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 5510, "confidence": 0.7, "source": "product", "roe": 100.0, "opMargin": 2.7, "debtRatio": 58.7, "revCagr": -45.4, "profGrade": "우수", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "215360", "corpName": "우리산업", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 5320, "confidence": 0.7, "source": "product", "roe": 3.5, "opMargin": 3.6, "debtRatio": 196.1, "revCagr": 2.1, "profGrade": "저수익", "debtGrade": "주의", "growthGrade": "고성장" }, { "stockCode": "043150", "corpName": "바텍", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 4264, "confidence": 1.0, "source": "product", "roe": 80.5, "opMargin": 10.5, "debtRatio": 39.7, "revCagr": 5.0, "profGrade": "우수", "debtGrade": "안전", "growthGrade": "정체" }, { "stockCode": "036030", "corpName": "케이티알파", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 3959, "confidence": 0.7, "source": "product", "roe": 0.6, "opMargin": 2.0, "debtRatio": 76.8, "revCagr": null, "profGrade": "저수익", "debtGrade": "안전", "growthGrade": "" }, { "stockCode": "125020", "corpName": "티씨머티리얼즈", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 2991, "confidence": 0.7, "source": "product", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" }, { "stockCode": "100120", "corpName": "뷰웍스", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 2393, "confidence": 1.0, "source": "product", "roe": 3.8, "opMargin": 15.2, "debtRatio": 47.0, "revCagr": 4.3, "profGrade": "양호", "debtGrade": "안전", "growthGrade": "정체" }, { "stockCode": "041830", "corpName": "인바디", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 2339, "confidence": 1.0, "source": "docs", "roe": 4.9, "opMargin": 19.0, "debtRatio": 15.3, "revCagr": 16.7, "profGrade": "양호", "debtGrade": "안전", "growthGrade": "성장" }, { "stockCode": "336570", "corpName": "원텍", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 1568, "confidence": 0.8, "source": "docs", "roe": 6.4, "opMargin": 27.8, "debtRatio": 39.1, "revCagr": 12.1, "profGrade": "우수", "debtGrade": "안전", "growthGrade": "성장" }, { "stockCode": "214680", "corpName": "디알텍", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 1163, "confidence": 1.0, "source": "product", "roe": -1.2, "opMargin": -1.9, "debtRatio": 169.2, "revCagr": 11.3, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "성장" }, { "stockCode": "228850", "corpName": "레이언스", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 1147, "confidence": 0.7, "source": "product", "roe": 112.0, "opMargin": 9.8, "debtRatio": 13.1, "revCagr": -0.9, "profGrade": "우수", "debtGrade": "안전", "growthGrade": "역성장" }, { "stockCode": "240550", "corpName": "동방메디컬", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 1135, "confidence": 0.5, "source": "docs", "roe": 4.0, "opMargin": 19.3, "debtRatio": 43.4, "revCagr": 19.9, "profGrade": "양호", "debtGrade": "안전", "growthGrade": "성장" }, { "stockCode": "122310", "corpName": "제노레이", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 1080, "confidence": 0.8, "source": "docs", "roe": -0.5, "opMargin": -6.2, "debtRatio": 65.3, "revCagr": 9.5, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "정체" }, { "stockCode": "263690", "corpName": "디알젬", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 1027, "confidence": 0.7, "source": "product", "roe": 4.2, "opMargin": 10.0, "debtRatio": 36.2, "revCagr": 3.4, "profGrade": "양호", "debtGrade": "안전", "growthGrade": "정체" }, { "stockCode": "179290", "corpName": "엠아이텍", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 672, "confidence": 0.8, "source": "docs", "roe": null, "opMargin": 29.4, "debtRatio": 15.1, "revCagr": -75.1, "profGrade": "우수", "debtGrade": "안전", "growthGrade": "급감" }, { "stockCode": "041920", "corpName": "메디아나", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 649, "confidence": 1.0, "source": "docs", "roe": 1.7, "opMargin": 10.0, "debtRatio": 11.0, "revCagr": -4.1, "profGrade": "양호", "debtGrade": "관찰", "growthGrade": "역성장" }, { "stockCode": "081180", "corpName": "쎄크", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 592, "confidence": 1.0, "source": "docs", "roe": -6.9, "opMargin": 1.3, "debtRatio": 178.2, "revCagr": null, "profGrade": "저수익", "debtGrade": "주의", "growthGrade": "" }, { "stockCode": "206560", "corpName": "덱스터", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 554, "confidence": 0.7, "source": "product", "roe": -13.0, "opMargin": -36.5, "debtRatio": 158.2, "revCagr": -12.7, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "037950", "corpName": "엘컴텍", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 463, "confidence": 0.7, "source": "product", "roe": 2.0, "opMargin": 8.3, "debtRatio": 18.5, "revCagr": -31.9, "profGrade": "보통", "debtGrade": "안전", "growthGrade": "고성장" }, { "stockCode": "156100", "corpName": "엘앤케이바이오", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 389, "confidence": 0.8, "source": "docs", "roe": 13.4, "opMargin": 1.1, "debtRatio": 115.6, "revCagr": 10.4, "profGrade": "양호", "debtGrade": "주의", "growthGrade": "성장" }, { "stockCode": "398120", "corpName": "에스지헬스케어", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 246, "confidence": 1.0, "source": "docs", "roe": -1.8, "opMargin": -8.7, "debtRatio": 66.3, "revCagr": null, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "" }, { "stockCode": "302550", "corpName": "리메드", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 245, "confidence": 0.8, "source": "docs", "roe": 2.5, "opMargin": 9.5, "debtRatio": 39.5, "revCagr": 19.9, "profGrade": "보통", "debtGrade": "안전", "growthGrade": "성장" }, { "stockCode": "296640", "corpName": "이노룰스", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 229, "confidence": 0.7, "source": "product", "roe": 1.9, "opMargin": 6.4, "debtRatio": 17.9, "revCagr": 22.5, "profGrade": "보통", "debtGrade": "안전", "growthGrade": "고성장" }, { "stockCode": "258830", "corpName": "세종메디칼", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 185, "confidence": 1.0, "source": "docs", "roe": 4.1, "opMargin": 19.0, "debtRatio": 158.2, "revCagr": -35.3, "profGrade": "양호", "debtGrade": "안전", "growthGrade": "급감" }, { "stockCode": "043090", "corpName": "더테크놀로지", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 126, "confidence": 0.7, "source": "product", "roe": 2.2, "opMargin": -13.6, "debtRatio": 35.9, "revCagr": 56.6, "profGrade": "저수익", "debtGrade": "주의", "growthGrade": "고성장" }, { "stockCode": "411080", "corpName": "샌즈랩", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 116, "confidence": 0.7, "source": "product", "roe": -1.2, "opMargin": -55.2, "debtRatio": 3.8, "revCagr": -84.3, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "058110", "corpName": "멕아이씨에스", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 113, "confidence": 0.867, "source": "docs", "roe": 1.8, "opMargin": 9.4, "debtRatio": 54.0, "revCagr": 2.4, "profGrade": "보통", "debtGrade": "관찰", "growthGrade": "정체" }, { "stockCode": "405000", "corpName": "플라즈맵", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 85, "confidence": 0.8, "source": "docs", "roe": -66.6, "opMargin": -76.2, "debtRatio": 437.4, "revCagr": 1.5, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "정체" }, { "stockCode": "0088M0", "corpName": "메쥬", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 74, "confidence": 1.0, "source": "docs", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" }, { "stockCode": "412350", "corpName": "레이저쎌", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 47, "confidence": 0.8, "source": "docs", "roe": -10.1, "opMargin": -142.8, "debtRatio": 127.6, "revCagr": -25.7, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "급감" }, { "stockCode": "212310", "corpName": "오건에코텍", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 0, "confidence": 0.8, "source": "docs", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "주의", "growthGrade": "" }, { "stockCode": "244880", "corpName": "나눔테크", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 0, "confidence": 1.0, "source": "docs", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" }, { "stockCode": "332190", "corpName": "오션스바이오", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 0, "confidence": 1.0, "source": "docs", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" }, { "stockCode": "337840", "corpName": "유엑스엔", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 0, "confidence": 0.8, "source": "docs", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" }, { "stockCode": "390110", "corpName": "애니메디솔루션", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 0, "confidence": 0.7, "source": "docs", "roe": null, "opMargin": null, "debtRatio": null, "revCagr": null, "profGrade": "", "debtGrade": "", "growthGrade": "" }, { "stockCode": "491000", "corpName": "리브스메드", "stage": "imaging", "role": "제조", "stream": "midstream", "revenue": 0, "confidence": 0.5, "source": "docs", "roe": -3.4, "opMargin": -81.5, "debtRatio": 13.2, "revCagr": -80.0, "profGrade": "적자", "debtGrade": "주의", "growthGrade": "급감" } ] } ], "unclassified": [], "edges": [ { "from": "228850", "to": "043150", "type": "supplier", "amount": null, "ratio": null, "product": "", "confidence": 0.9, "source": "docs_table" }, { "from": "036220", "to": "336040", "type": "affiliate", "amount": null, "ratio": null, "product": "", "confidence": 0.5, "source": "docs" }, { "from": "043150", "to": "228850", "type": "affiliate", "amount": null, "ratio": null, "product": "", "confidence": 0.5, "source": "docs" }, { "from": "044780", "to": "200580", "type": "supplier", "amount": null, "ratio": null, "product": "", "confidence": 0.7, "source": "docs" }, { "from": "228850", "to": "043150", "type": "affiliate", "amount": null, "ratio": null, "product": "", "confidence": 0.5, "source": "docs" }, { "from": "036220", "to": "336040", "type": "investor", "amount": null, "ratio": null, "product": "", "confidence": 0.6, "source": "network" } ] }